Enzo Biochem, Inc. (ENZ)
USD 0.31
(-17.77%)
USD 0.31
(-17.77%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 | 26.99 Million USD | -13.21% |
| 2023 | 31.1 Million USD | -45.88% |
| 2022 | 57.47 Million USD | 19.35% |
| 2021 | 48.15 Million USD | 1.58% |
| 2020 | 47.4 Million USD | -0.07% |
| 2019 | 47.44 Million USD | -7.64% |
| 2018 | 51.36 Million USD | 3.32% |
| 2017 | 49.71 Million USD | 0.54% |
| 2016 | 49.44 Million USD | 5.87% |
| 2015 | 46.7 Million USD | -2.71% |
| 2014 | 48 Million USD | -7.75% |
| 2013 | 52.03 Million USD | -17.46% |
| 2012 | 63.04 Million USD | 3.13% |
| 2011 | 61.13 Million USD | -6.34% |
| 2010 | 65.27 Million USD | 7.77% |
| 2009 | 60.56 Million USD | 15.68% |
| 2008 | 52.35 Million USD | 3.39% |
| 2007 | 50.64 Million USD | 15.39% |
| 2006 | 43.88 Million USD | 12.64% |
| 2005 | 38.96 Million USD | -4.43% |
| 2004 | 40.77 Million USD | 11.35% |
| 2003 | 36.61 Million USD | 7.13% |
| 2002 | 34.17 Million USD | 7.64% |
| 2001 | 31.75 Million USD | 2.96% |
| 2000 | 30.84 Million USD | 15.51% |
| 1999 | 26.7 Million USD | 3.49% |
| 1998 | 25.8 Million USD | 20.56% |
| 1997 | 21.4 Million USD | -4.46% |
| 1996 | 22.4 Million USD | 5.16% |
| 1995 | 21.3 Million USD | 53.24% |
| 1994 | 13.9 Million USD | -24.46% |
| 1993 | 18.4 Million USD | 35.29% |
| 1992 | 13.6 Million USD | 1033.33% |
| 1991 | 1.2 Million USD | -92.64% |
| 1990 | 16.3 Million USD | 30.4% |
| 1989 | 12.5 Million USD | 23.76% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 5.64 Million USD | -28.11% |
| 2024 Q4 | 8.41 Million USD | 13.69% |
| 2024 Q1 | 7.85 Million USD | 203.63% |
| 2024 Q3 | 5.08 Million USD | -9.99% |
| 2023 FY | 31.1 Million USD | -45.88% |
| 2023 Q4 | -7.58 Million USD | -158.33% |
| 2023 Q1 | 12.44 Million USD | -30.14% |
| 2023 Q2 | 13.24 Million USD | 6.4% |
| 2023 Q3 | 12.99 Million USD | -1.86% |
| 2022 Q1 | 11.79 Million USD | -6.82% |
| 2022 FY | 57.47 Million USD | 19.35% |
| 2022 Q4 | 17.81 Million USD | 41.69% |
| 2022 Q3 | 12.57 Million USD | -17.74% |
| 2022 Q2 | 15.28 Million USD | 29.59% |
| 2021 FY | 48.15 Million USD | 1.58% |
| 2021 Q3 | 12.91 Million USD | 9.3% |
| 2021 Q4 | 12.66 Million USD | -2.0% |
| 2021 Q1 | 10.76 Million USD | -4.21% |
| 2021 Q2 | 11.81 Million USD | 9.84% |
| 2020 FY | 47.4 Million USD | -0.07% |
| 2020 Q1 | 12.19 Million USD | 4.12% |
| 2020 Q4 | 11.23 Million USD | -8.11% |
| 2020 Q2 | 11.75 Million USD | -3.57% |
| 2020 Q3 | 12.22 Million USD | 3.96% |
| 2019 Q3 | 11.7 Million USD | -5.1% |
| 2019 Q1 | 11.69 Million USD | -16.63% |
| 2019 Q4 | 11.71 Million USD | 0.09% |
| 2019 Q2 | 12.33 Million USD | 5.4% |
| 2019 FY | 47.44 Million USD | -7.64% |
| 2018 Q3 | 12.22 Million USD | -3.48% |
| 2018 Q2 | 12.66 Million USD | 1.68% |
| 2018 Q1 | 12.45 Million USD | -0.65% |
| 2018 FY | 51.36 Million USD | 3.32% |
| 2018 Q4 | 14.03 Million USD | 14.83% |
| 2017 Q4 | 12.53 Million USD | 5.43% |
| 2017 Q3 | 11.88 Million USD | -3.56% |
| 2017 FY | 49.71 Million USD | 0.54% |
| 2017 Q2 | 12.32 Million USD | -4.92% |
| 2017 Q1 | 12.96 Million USD | 1.9% |
| 2016 Q4 | 12.72 Million USD | 3.21% |
| 2016 Q1 | 11.79 Million USD | -5.15% |
| 2016 Q3 | 12.32 Million USD | -2.17% |
| 2016 FY | 49.44 Million USD | 5.87% |
| 2016 Q2 | 12.6 Million USD | 6.82% |
| 2015 Q4 | 12.43 Million USD | 7.74% |
| 2015 Q2 | 11.1 Million USD | -4.41% |
| 2015 FY | 46.7 Million USD | -2.71% |
| 2015 Q1 | 11.61 Million USD | -1.73% |
| 2015 Q3 | 11.54 Million USD | 3.95% |
| 2014 FY | 48 Million USD | -7.75% |
| 2014 Q1 | 12.21 Million USD | 2.9% |
| 2014 Q2 | 11.82 Million USD | -3.19% |
| 2014 Q3 | 12.13 Million USD | 2.62% |
| 2014 Q4 | 11.82 Million USD | -2.6% |
| 2013 FY | 52.03 Million USD | -17.46% |
| 2013 Q4 | 11.87 Million USD | -8.3% |
| 2013 Q3 | 12.94 Million USD | -1.86% |
| 2013 Q2 | 13.19 Million USD | -16.06% |
| 2013 Q1 | 15.72 Million USD | -1.27% |
| 2012 FY | 63.04 Million USD | 3.13% |
| 2012 Q4 | 15.92 Million USD | 2.21% |
| 2012 Q3 | 15.57 Million USD | 1.27% |
| 2012 Q2 | 15.38 Million USD | -4.84% |
| 2012 Q1 | 16.16 Million USD | 0.69% |
| 2011 Q4 | 16.05 Million USD | 9.73% |
| 2011 FY | 61.13 Million USD | -6.34% |
| 2011 Q3 | 14.63 Million USD | -7.96% |
| 2011 Q2 | 15.89 Million USD | 9.17% |
| 2011 Q1 | 14.56 Million USD | -23.73% |
| 2010 Q4 | 19.09 Million USD | 25.6% |
| 2010 Q3 | 15.19 Million USD | -7.33% |
| 2010 FY | 65.27 Million USD | 7.77% |
| 2010 Q2 | 16.4 Million USD | 7.96% |
| 2010 Q1 | 15.19 Million USD | 0.64% |
| 2009 FY | 60.56 Million USD | 15.68% |
| 2009 Q2 | 16.04 Million USD | 9.55% |
| 2009 Q3 | 14.33 Million USD | -10.66% |
| 2009 Q4 | 15.09 Million USD | 5.3% |
| 2009 Q1 | 14.64 Million USD | 9.7% |
| 2008 Q2 | 14.24 Million USD | 12.03% |
| 2008 Q4 | 13.35 Million USD | 10.79% |
| 2008 FY | 52.35 Million USD | 3.39% |
| 2008 Q1 | 12.71 Million USD | -9.82% |
| 2008 Q3 | 12.05 Million USD | -15.4% |
| 2007 FY | 50.64 Million USD | 15.39% |
| 2007 Q4 | 14.09 Million USD | 6.52% |
| 2007 Q3 | 13.23 Million USD | 3.4% |
| 2007 Q2 | 12.8 Million USD | 21.88% |
| 2007 Q1 | 10.5 Million USD | -8.74% |
| 2006 FY | 43.88 Million USD | 12.64% |
| 2006 Q4 | 11.5 Million USD | 11.85% |
| 2006 Q3 | 10.29 Million USD | -14.8% |
| 2006 Q2 | 12.07 Million USD | 20.62% |
| 2006 Q1 | 10.01 Million USD | -8.28% |
| 2005 Q1 | 8.96 Million USD | -18.74% |
| 2005 FY | 38.96 Million USD | -4.43% |
| 2005 Q4 | 10.91 Million USD | 9.13% |
| 2005 Q3 | 10 Million USD | 10.25% |
| 2005 Q2 | 9.07 Million USD | 1.17% |
| 2004 Q3 | 9.9 Million USD | -11.3% |
| 2004 Q1 | 8.66 Million USD | -31.6% |
| 2004 FY | 40.77 Million USD | 11.35% |
| 2004 Q4 | 11.03 Million USD | 11.46% |
| 2004 Q2 | 11.16 Million USD | 28.78% |
| 2003 Q3 | 7.29 Million USD | -13.5% |
| 2003 Q2 | 8.43 Million USD | 2.86% |
| 2003 Q1 | 8.2 Million USD | -15.07% |
| 2003 Q4 | 12.67 Million USD | 73.65% |
| 2003 FY | 36.61 Million USD | 7.13% |
| 2002 FY | 34.17 Million USD | 7.64% |
| 2002 Q1 | 7.89 Million USD | 13.44% |
| 2002 Q2 | 7.98 Million USD | 1.1% |
| 2002 Q3 | 8.57 Million USD | 7.39% |
| 2002 Q4 | 9.65 Million USD | 12.62% |
| 2001 Q1 | 8.32 Million USD | -4.17% |
| 2001 Q2 | 8.46 Million USD | 1.61% |
| 2001 Q3 | 7.99 Million USD | -5.48% |
| 2001 Q4 | 6.96 Million USD | -12.95% |
| 2001 FY | 31.75 Million USD | 2.96% |
| 2000 Q3 | 7.69 Million USD | 3.97% |
| 2000 FY | 30.84 Million USD | 15.51% |
| 2000 Q1 | 7.1 Million USD | 14.52% |
| 2000 Q2 | 7.4 Million USD | 4.23% |
| 2000 Q4 | 8.69 Million USD | 12.96% |
| 1999 Q4 | 6.2 Million USD | -10.14% |
| 1999 Q1 | 6.6 Million USD | 4.76% |
| 1999 FY | 26.7 Million USD | 3.49% |
| 1999 Q2 | 7 Million USD | 6.06% |
| 1999 Q3 | 6.9 Million USD | -1.43% |
| 1998 Q1 | 6.1 Million USD | -4.69% |
| 1998 Q2 | 6.5 Million USD | 6.56% |
| 1998 FY | 25.8 Million USD | 20.56% |
| 1998 Q4 | 6.3 Million USD | -8.7% |
| 1998 Q3 | 6.9 Million USD | 6.15% |
| 1997 Q4 | 6.4 Million USD | 25.49% |
| 1997 Q1 | 4.9 Million USD | -55.05% |
| 1997 Q2 | 4.8 Million USD | -2.04% |
| 1997 FY | 21.4 Million USD | -4.46% |
| 1997 Q3 | 5.1 Million USD | 6.25% |
| 1996 Q1 | 4.3 Million USD | -47.56% |
| 1996 Q4 | 10.9 Million USD | 186.84% |
| 1996 Q3 | 3.8 Million USD | -19.15% |
| 1996 Q2 | 4.7 Million USD | 9.3% |
| 1996 FY | 22.4 Million USD | 5.16% |
| 1995 Q4 | 8.2 Million USD | 64.0% |
| 1995 Q2 | 3.3 Million USD | -19.51% |
| 1995 FY | 21.3 Million USD | 53.24% |
| 1995 Q1 | 4.1 Million USD | 2.5% |
| 1995 Q3 | 5 Million USD | 51.52% |
| 1994 Q4 | 4 Million USD | 14.29% |
| 1994 Q3 | 3.5 Million USD | 0.0% |
| 1994 FY | 13.9 Million USD | -24.46% |
| 1994 Q1 | 3.1 Million USD | -62.65% |
| 1994 Q2 | 3.5 Million USD | 12.9% |
| 1993 Q3 | 3.3 Million USD | 0.0% |
| 1993 Q4 | 8.3 Million USD | 151.52% |
| 1993 Q2 | 3.3 Million USD | -5.71% |
| 1993 Q1 | 3.5 Million USD | 6.06% |
| 1993 FY | 18.4 Million USD | 35.29% |
| 1992 Q1 | 3.5 Million USD | 128.46% |
| 1992 Q4 | 3.3 Million USD | -10.81% |
| 1992 FY | 13.6 Million USD | 1033.33% |
| 1992 Q3 | 3.7 Million USD | 23.33% |
| 1992 Q2 | 3 Million USD | -14.29% |
| 1991 Q1 | 4.4 Million USD | 51.72% |
| 1991 FY | 1.2 Million USD | -92.64% |
| 1991 Q2 | 4.6 Million USD | 4.55% |
| 1991 Q4 | -12.3 Million USD | -367.39% |
| 1991 Q3 | 4.6 Million USD | 0.0% |
| 1990 Q1 | 3.9 Million USD | 124.22% |
| 1990 Q4 | 2.9 Million USD | -39.58% |
| 1990 FY | 16.3 Million USD | 30.4% |
| 1990 Q2 | 4.7 Million USD | 20.51% |
| 1990 Q3 | 4.8 Million USD | 2.13% |
| 1989 FY | 12.5 Million USD | 23.76% |
| 1989 Q1 | - USD | 100.0% |
| 1989 Q3 | - USD | 0.0% |
| 1989 Q4 | -16.1 Million USD | 0.0% |
| 1989 Q2 | - USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Agilent Technologies, Inc. | 2.11 Billion USD | 98.724% |
| Charles River Laboratories International, Inc. | 885.29 Million USD | 96.951% |
| Quest Diagnostics Incorporated | 1.61 Billion USD | 98.323% |
| Danaher Corporation | 8.83 Billion USD | 99.694% |
| IQVIA Holdings Inc. | 2.05 Billion USD | 98.685% |
| Laboratory Corporation of America Holdings | 2.02 Billion USD | 98.664% |
| Mettler-Toledo International Inc. | 1.08 Billion USD | 97.522% |
| Qiagen N.V. | 777.67 Million USD | 96.529% |
| Revvity, Inc. | 874.01 Million USD | 96.911% |
| Thermo Fisher Scientific Inc. | 10.25 Billion USD | 99.737% |
| Waters Corporation | 943.51 Million USD | 97.139% |